Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 2, 2018
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
Reni Benjamin Downgraded (ADVM) to Hold on, Nov 2nd, 2018
Reni Benjamin of Raymond James, Downgraded "Adverum Biotechnologies, Inc." (ADVM) to Hold on, Nov 2nd, 2018.
Reni has made no other calls on ADVM in the last 4 months.
There is 1 other peer that has a rating on ADVM. Out of the 1 peers that are also analyzing ADVM, 0 agree with Reni's Rating of Hold.
This is the rating of the analyst that currently disagrees with Reni
- Alethia Young of "Cantor Fitzgerald" Initiated at Buy and Held Target at $120 on, Friday, September 21st, 2018
